Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

ERDV:GR

33.8300 EUR 0.9200 2.80%

As of 15:56:55 ET on 03/27/2015.

Snapshot for BlackRock Global Funds - World Healthscience Fund (ERDV)

Open: 32.6900 High - Low: 33.8300 - 32.6900 Primary Exchange: Berlin
Volume: 2,778 52-Week Range: 19.1500 - 35.1800 Beta vs NDWUHC: 0.9768

ETF Chart for ERDV

No chart data available.
  • ERDV:GR 33.8300
  • 1D
  • 1M
  • 1Y
32.9100
Interactive ERDV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ERDV

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 2001-04-06 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for ERDV

NAV (on 2015-03-26) 32.9500
Assets (M) (on 2015-02-27) 3,498.8850
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.12
Average 52-Week % Premium -0.6365
Fund Leveraged N

Dividends for ERDV

No dividends reported

Performance for ERDV

1-Month +7.57% 1-Year +65.43%
3-Month +25.20% 3-Year +36.13%
Year To Date +22.79% 5-Year +23.23%
Expense Ratio 1.84

Top Fund Holdings for ERDV

Filing Date: 02/27/2015
Name Position Value % of Total
Novartis AG 1,400,300 143,944,341 4.166%
Biogen Inc 304,907 124,886,858 3.615%
Celgene Corp 977,508 118,796,547 3.438%
UnitedHealth Group Inc 1,004,933 114,190,537 3.305%
Actavis plc 360,492 105,032,949 3.040%
Amgen Inc 614,500 96,918,940 2.805%
Merck & Co Inc 1,647,100 96,421,234 2.791%
Medtronic PLC 1,233,179 95,682,359 2.769%
Roche Holding AG 349,800 95,493,924 2.764%
Abbott Laboratories 1,781,100 84,370,707 2.442%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil